EIF4EBP1 and lung adenocarcinoma: Clinical analysis revealed subtype-specific prognostic value, where high EIF4EBP1 expression correlated with poor survival in lung adenocarcinoma (LUAD) but favorable outcomes in squamous cell carcinoma (LUSC).